RxDoctor Payments Data

Lisa Miller, MD

Family Medicine · Greensboro, NCNPI 1962571760

Payments from drug & device makers

$841in general payments, 2019–2025

Across 43 payments — averaging $19.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$281
  • GSK$107
  • Amgen$97
  • AbbVie$92
  • Galderma Laboratories, L.p.$85
  • Astellas Pharma US Inc$30
  • plus $149 from 8 others

What the payments were for

  • Food & beverage$841100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$841 in reported general payments places this provider in the 65th percentile of 3,444 family medicine providers in North Carolina.

See all family medicine providers in North Carolina

Medicare billing

Part B allowed, 2024
$114,436
Medicare patients
266
Services billed
2,439

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin70$73,944
MounjaroTirzepatide47$56,430
EliquisApixaban40$38,076
OzempicSemaglutide40$37,793
FarxigaDapagliflozin Propanediol33$36,554
XareltoRivaroxaban34$29,995
RybelsusSemaglutide11$22,853
AbrysvoRsv Vacc, Pref A And Pref B/Pf64$20,458
JanuviaSitagliptin Phosphate12$19,699
Atorvastatin Calcium969$10,729
ShingrixVaricella-Zoster Ge/As01b/Pf43$9,619
Breo ElliptaFluticasone/Vilanterol16$7,763
Rosuvastatin Calcium517$6,074
SymbicortBudesonide/Formoterol Fumarate21$5,920
Levothyroxine Sodium424$5,627

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$13$60,64651 claims
Lilly USA, LLCMounjaro$12$56,43047 claims
Johnson & JohnsonXarelto$11$29,99534 claims
MerckJanuvia$26$19,69912 claims
GSKShingrix, Breo Ellipta$107$17,38259 claims
AbbVieSynthroid$92$4,82258 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 3,444 family medicine providers in North Carolina.

Other family medicine in Greensboro

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →